Pharming Group reports financial results for the first quarter of 2023 ...Middle East

FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues decreased by 9% to US$42.5 million, compared to the first quarter of 2022, primarily due to temporary reimbursement disruptions for some...

Hence then, the article about pharming group reports financial results for the first quarter of 2023 was published today ( Thursday 11/05/2023 - 08:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming Group reports financial results for the first quarter of 2023 )

Also on site :

• 1990 Tearjerker Voted ‘Best Country Song’ of All Time
• TJ Maxx Is Selling a Lookalike of a Popular Anthropologie Doormat Over 3x the Price
• The Cozy One-Pot Dinner I’m Making on Repeat All Winter Long